摘要
目的研究抑癌基因PTEN和胰岛素样生长因子1受体(IGF1R)与子宫内膜癌临床及病理特征的关系。方法应用免疫组织化学方法(SP法)检测45例子宫内膜癌组织中PTEN基因和胰岛素样生长因子1受体的表达。结果45例子宫内膜癌组织中,PTEN阳性表达率为28.89%;Ⅰ期患者和Ⅱ~Ⅲ期患者阳性表达率分别为44.00%和10.00%(P<0.05);在高、中、低分化子宫内膜癌中的阳性表达率分别为60.00%、15.00%和10.00%(P<0.05);无、有淋巴结转移者的阳性表达率分别为38.71%和7.14%(P<0.05);IGF1R阳性表达率为86.67%。结论PTEN基因抑制子宫内膜癌的生长、浸润及淋巴结转移;IGF1R在子宫内膜癌的发生中发挥着重要作用。
Objective To study the expression of PTEN gene and IGF-1R in endometrial cancers and clarify the relationship between the expression and the clinicopathological parameter.Methods The expression of PTEN and IGF-1R in 45 samples of endometrial cancer tissues were detected by immunohistochemical stainings.Results The expression of PTEN in endometrial cancer tissues was 28.89%.The positive rate in clinical cancer stages Ⅰ and Ⅱ~Ⅲ was 44.00% and 10.00%(P<0.05) respectively.The positive rate in the high,middle and low pathohistologic grading was 60.00%,15.00% and 10.00%,respectively(P<0.05).38.71% of the cases without and 7.14% of the cases with node metastasis showed positive for PTEN(P<0.05).The expression of IGF-1R in endometrial cancers tissues was 86.67%.Conclusions PTEN gene may inhibit the growth,invasion and metastasis of endometrial cancer.IGF-1R plays an important role in pathogenesis and development of endometrial cancers.
出处
《中国基层医药》
CAS
2005年第6期684-685,共2页
Chinese Journal of Primary Medicine and Pharmacy